Why the study?
Do admission platelet volume indices (MPV and PDW) predict no reflow and in-hospital MACEs in patients with STEMI undergoing primary PCI?
Do admission platelet volume indices (MPV and PDW) predict no reflow and in-hospital MACEs in patients with STEMI undergoing primary PCI?
Answers are grounded in this paper and cite their sources.
Admission platelet distribution width and mean platelet volume are independent predictors of no reflow and in-hospital MACEs in STEMI patients undergoing primary PCI.
Although mean platelet volume (MPV) is an independent correlate of impaired angiographic reperfusion and 6-month mortality in ST-segment elevation myocardial infarction (STEMI) treated with primary percutaneous coronary intervention (pPCI), there is less data regarding the association between platelet distribution width (PDW) and in-hospital major adverse cardiovascular events (MACEs). A total of 306 patients with STEMI pPCI were evaluated. No reflow was defined as a post-PCI thrombolysis in myocardial infarction (TIMI) flow grade of 0, 1, or 2 (group 1). Angiographic success was defined as TIMI flow grade 3 (group 2). The values of MPV and PDW were higher among patients with no reflow. In-stent thrombosis, nonfatal myocardial infarction, in-hospital mortality, and MACEs were significantly more frequent among patients with no reflow. In multivariate analysis, PDW, MPV, high-sensitivity C-reactive protein, and glucose on admission were independent correlates of in-hospital MACEs. Admission PDW and MPV are independent correlates of no reflow and in-hospital MACEs among patients with STEMI undergoing pPCI.
No takes yet. Share an insight, caveat, or question.
Celık et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: